MiNK Therapeutics, Inc. - INKT Bozor qiymatining balans qiymatiga nisbati

INKT (MiNK Therapeutics, Inc.) - kompaniyaning tovar belgisi

MiNK Therapeutics, Inc. (INKT) uchun bozor baholash dinamikasi klinik sinovlar doirasida qattiq o'smalarga qarshi kurashishning innovatsion usullarini ishlab chiqishga asoslangan bo'lib, bunda joriy ko'rsatkich -3.85 darajasida turibdi. MiNK Therapeutics, Inc. (INKT) ilg'or iNKT yechimlarini yaratganligi sababli ilmiy hamjamiyatda yuqori nufuzga ega. Yuqori o'sish potentsiali hamyonbop terapiya dozalarining ommaviy ishlab chiqarilishini ta'minlovchi noyob platformalar hisobiga shakllanmoqda.

MiNK Therapeutics, Inc (INKT) Kapitallashuvning balans qiymatiga nisbati: 04.07.2022 - 31.10.2026 davri uchun
MiNK ishlab chiqargan mahsulot

Ushbu koeffitsient joriy valyuta ayirboshlash kurslari prizmasi orqali sof aktivlarning bir dollari qiymatini belgilaydi. Market-to-book koeffitsientini tahlil qilish orqali investor biznesning moddiy aktivlar bazasi uchun to'langan premiumning miqdorini aniqlaydi. Ushbu metrika haddan tashqari yuqori baholangan sohalarni aniqlash uchun bozor kapitalizatsiyasini kapitalning balans qiymati bilan solishtiradi. MiNK Therapeutics, Inc. (INKT) uchun ushbu muvozanat juda muhimdir, chunki uning innovatsion iNKT terapiyalarining qiymati intellektual kapitaliga kiritilgan. Ushbu koeffitsientning yuqori qiymatlari bu yerda saratonni davolash usullarining kengayishiga bo'lgan bozor kutganlarini aks ettiradi.

Raqobatdosh kompaniyalar tahlili

IBRX (ImmunityBio, Inc.) - Kapitallashuvning sof aktivlarga nisbati|IMCR: Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati Janux Therapeutics, Inc.|Bozor qiymatining balans qiymatiga koeffitsiyenti Arcus Biosciences Inc RCUS|Bozor qiymatining balans qiymatiga nisbati Zymeworks Corp (ZYME)|Tango Therapeutics Corp - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IOVA (Iovance Biotherapeutics)|IMTX - Kapitallashuvning sof aktivlarga nisbati|XNCR - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Compass Therapeutics Inc|Replimune Corp (REPL) - Bozor qiymatining balans qiymatiga nisbati|LYEL (Lyell Pharma) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Innate Pharma S.A.|Bozor qiymatining balans qiymatiga koeffitsiyenti Pyxis PYXS|Bozor kapitallashuvining balans qiymatiga nisbati CGEN|IO Biotech Inc (IOBT) - Bozor qiymatining xususiy kapitalga nisbati|Sutro Bio - Kapitallashuvning sof aktivlarga nisbati|Werewolf Therapeutics Inc. (HOWL) - Bozor qiymatining balans qiymatiga koeffitsiyenti|IMMX: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati ALXO (alxoncology.com)|CUE: Bozor kapitallashuvining balans qiymatiga nisbati|PDSB - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Sonnet BioTherapeutics Holdings, Inc.|Kapitallashuvning sof aktivlarga nisbati MAIA Bio (MAIA)|Bozor qiymatining balans qiymatiga nisbati Liminatus Pharma (LIMN)|Kapitallashuvning sof aktivlarga nisbati lavatherapeutics.com LVTX|NextCure - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Leap Therapeutics Inc LPTX|INTS - Bozor qiymatining balans qiymatiga nisbati|SNSE (Sensei Biotherapeutics) - Kapitallashuvning balans qiymatiga nisbati|Theriva Biologics, Inc. (TOVX) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Gritstone bio (GRTS)|Kapitallashuvning sof aktivlarga nisbati KA|NEXI - Bozor qiymatining xususiy kapitalga nisbati|Kapitallashuvning sof aktivlarga nisbati TSBX (Turnstone Biologics)|Bozor kapitallashuvining balans qiymatiga multiplikatori VCNX|Bozor kapitallashuvining balans qiymatiga nisbati HARP (Harpoon Therapeutics)